ALESHA WILHELM: Open Payments
NPI 1265213649 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,817 in 115 payments from 23 companies in 2025. Trend: 2023 $189 · 2024 $2,411 · 2025 $2,817
Food & beverage: $2,704Education: $113
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $534 |
| GlaxoSmithKline, LLC. | 20 | $308 |
| Inspire Medical Systems, Inc. | 6 | $306 |
| Actelion Pharmaceuticals US, Inc. | 6 | $232 |
| Verona Pharma, Inc. | 8 | $213 |
| Avadel CNS Pharmaceuticals, LLC | 7 | $161 |
| Axsome Therapeutics, Inc. | 8 | $157 |
| GENZYME CORPORATION | 7 | $153 |
| Amgen Inc. | 7 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $85 |
Products named: INSPIRE, DUPIXENT, FASENRA, NUCALA, Ohtuvayre, TEZSPIRE, UPTRAVI, LUMRYZ.
Industry payments across GA — which companies pay providers there.
